Elite in Heart Failure

Jozef Bartunek

Aalst, VLG, BE 
Elite in Heart Failure
Aalst, VLG, BE 
OverviewLocationsClinical Research

Overview

Jozef Bartunek practices in Aalst, Belgium. Mr. Bartunek is rated as an Elite expert by MediFind in the treatment of Heart Failure. His top areas of expertise are Heart Failure, Stable Angina, Coronary Heart Disease, Percutaneous Coronary Intervention (PCI), and Heart Transplant.

His clinical research consists of co-authoring 225 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 74 articles and participated in 3 clinical trials in the study of Heart Failure.

Gender
Male

Locations

Aalst, VLG, Belgium

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Safety and Performance Evaluation of the AccuCinch® Ventricular Restoration System for the Treatment of Heart Failure With or Without Functional Mitral Regurgitation Due to Dilated Ischemic or Non-Ischemic Cardiomyopathy - The CorCinch-EU Study
Safety and Performance Evaluation of the AccuCinch® Ventricular Restoration System for the Treatment of Heart Failure With or Without Functional Mitral Regurgitation Due to Dilated Ischemic or Non-Ischemic Cardiomyopathy - The CorCinch-EU Study
Enrollment Status: Active_not_recruiting
Publish Date: January 29, 2025
Intervention Type: Device
Study Phase: Not Applicable
A Randomized, Double Blind, Placebo Controlled Clinical Study to Evaluate Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy
A Randomized, Double Blind, Placebo Controlled Clinical Study to Evaluate Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy
Enrollment Status: Completed
Publish Date: October 04, 2021
Intervention Type: Drug
Study Phase: Phase 3
Alfapump DSR System in the Treatment of Diuretic Resistant Heart Failure Subjects
Alfapump DSR System in the Treatment of Diuretic Resistant Heart Failure Subjects
Enrollment Status: Completed
Publish Date: May 28, 2021
Intervention Type: Device
Study Phase: Not Applicable
The Effect of Intracoronary Reinfusion of Bone Marrow-derived Mononuclear Cells(BM-MNC) on All Cause Mortality in Acute Myocardial Infarction.
The Effect of Intracoronary Reinfusion of Bone Marrow-derived Mononuclear Cells(BM-MNC) on All Cause Mortality in Acute Myocardial Infarction.
Enrollment Status: Completed
Publish Date: April 13, 2021
Intervention Type: Procedure
Study Phase: Phase 3
View 3 Less Clinical Trials

225 Total Publications

Late adaptive coronary artery remodelling after implantation of a biodegradable stent.
Late adaptive coronary artery remodelling after implantation of a biodegradable stent.
Journal: BMJ case reports
Published: August 14, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Bartunek's expertise for a condition
ConditionClose
View All 23 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile